Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jun 17:10:921323.
doi: 10.3389/fped.2022.921323. eCollection 2022.

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone

Affiliations
Case Reports

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone

Shimin Wu et al. Front Pediatr. .

Abstract

Background: Glycogen storage disease type Ia is a rare metabolic disorder that leads to excessive glycogen and fat accumulation in organs, characterized by hepatomegaly, hypoglycemia, lactic acidemia, hyperlipidemia, hyperuricemia, puberty delay, and growth retardation. Here, we report on a patient with glycogen storage disease type Ia treated with growth hormone.

Case presentation: A 10-year-old boy had growth retardation for 6 years, and was admitted to clarify the cause of his short stature. We found that his bone age was 5.5 years, significantly lower than his physical age, while his serum IGF-1 and IGFBP-3 were 23.30 and 1620.0 ng/mL, respectively, both lower than normal. His medical history revealed that he had suffered from steatohepatitis, hyperlipidemia, and hypoglycemia since he was 11 months of age. Whole exome sequencing (WES) showed compound heterozygous mutations in exons 2 and 5 of the glucose-6-phosphatase (G6PC) gene on chromosome 17: c.G248A (p.R83H) and c.G648T (p.L216L). The patient was finally diagnosed with GSD Ia. After growth hormone (GH) treatment and corn starch therapy for 14 months, his height significantly increased (by 13 cm). The serum IGF-1 level increased to the normal range but his lipid levels and liver function did not significantly increase.

Conclusion: We describe a young patient with a compound heterozygous G6PC variant in a Chinese family; his height increased significantly after growth hormone and corn starch interventions. This case emphasizes that WES is essential for early diagnosis, and that growth hormone treatment may increase the height of patients with GSD Ia safely.

Keywords: G6PC gene; GSD Ia; compound heterozygous variant; growth hormone treatment; growth retardation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The growth curve and bone ages. (A) The growth curve of Chinese boys (8). (B,C) Plain X-rays of the left hand and wrist.
FIGURE 2
FIGURE 2
Mutational analysis in the patient pedigree. (A) The genotypes of G6PC gene for family members. Roman numerals indicate generations and Arabic numbers indicate individuals. Squares, males; circles, females. Affected individuals are denoted by solid symbols and unaffected individuals are denoted by open symbols. The index patient is indicated by an arrow. The two mutations were inherited from father and mother, respectively. (B) Validation for two compound heterozygous points mutations (c.G248A and c.G648T) at the exon 2 and 5 by Sanger Sequencing. The red arrow showed proband.

Similar articles

Cited by

References

    1. Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American college of medical genetics and genomics. Genet Med. (2014) 16:e1. 10.1038/gim.2014.128 - DOI - PubMed
    1. Koeberl DD, Kishnani PS, Bali D, Chen YT. Emerging therapies for glycogen storage disease type I. Trends Endocrinol Metab. (2009) 20:252–8. 10.1016/j.tem.2009.02.003 - DOI - PubMed
    1. Veiga-da-Cunha M, Gerin I, Chen YT, Lee PJ, Leonard JV, Maire I, et al. The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet. (1999) 7:717–23. 10.1038/sj.ejhg.5200366 - DOI - PubMed
    1. Dambska M, Labrador EB, Kuo CL, Weinstein DA. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes. (2017) 18:327–31. 10.1111/pedi.12540 - DOI - PubMed
    1. Dagdelen S, Atmaca A, Alikasifoglu A, Erbas T. Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report. J Med Case Rep. (2008) 2:210. 10.1186/1752-1947-2-210 - DOI - PMC - PubMed

Publication types